Looking forward to news that could come from any angle and roast anyone who's short this stock in the next few weeks. Personally I'm very confident in B working for COVID-19 especially for the anti-inflammatory properties and being used as a support drug not just based on testing so far but it's also supported by past clinical trials. on 1/16/20 things changed and buying started coming in with a few gaps fills along the way. I will say though this week felt a little different... when is the last time we've had this many green days in a row? I believe accumulation is happening silently. If B is COVID-19 approved... double digits are in our future.

Not to mention news on B-OM Ph3 partnering but who knows we could be waiting till the Covid testing is complete to re-value the proposed agreements. If I was Leo I would hold off while the COVID testing could command a few 10 million more in support/partnering. There are a lot of hospitals that are only dealing with Covid patients right now so running other clinical trials right now would be at a snail's pace anyway.

This is all IMO though and I'm locked and loaded to the teeth. Looking forward to the future it's been a tough road but happy to support a company that will change people's lives for the better while bringing a whole new drug platform to the market instead of the typical wash and repeat with existing drugs.

Go IPIX